Medicine Description vronogabic 150 mg
vronogabic 150 mg capsules is a medication that primarily acts by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This interaction inhibits the release of several excitatory neurotransmitters, including glutamate, substance P, and noradrenaline, thereby modulating the transmission of pain signals and reducing neuronal excitability. By dampening these signals, vronogabic alleviates neuropathic pain and provides anticonvulsant effects.
Indications and Uses of vronogabic 150 mg capsules
- Treatment of partial onset seizures in conjunction with other antiepileptic medications.
- Management of neuropathic pain associated with diabetic peripheral neuropathy.
- Relief of pain linked to postherpetic neuralgia following herpes zoster infection.
- Alleviation of fibromyalgia-related pain.
Side Effects of vronogabic 150 mg capsules
- Dizziness
- Drowsiness
- Dry mouth
- Edema
- Blurred vision
- Weight gain
Storage and Handling
Store vronogabic capsules at room temperature, away from moisture and heat. Ensure that the medication is kept in its original packaging and out of reach of children.
Patient Advice and Precautions
Patients should be advised to avoid sudden discontinuation of vronogabic to prevent withdrawal symptoms. It is important to consult a healthcare provider before using this medication in conjunction with other CNS depressants. Regular follow-up appointments can help monitor therapeutic efficacy and side effects.